Xin Lü

9.6k total citations · 1 hit paper
67 papers, 3.3k citations indexed

About

Xin Lü is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xin Lü has authored 67 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Xin Lü's work include Gene expression and cancer classification (7 papers), Cellular Mechanics and Interactions (6 papers) and Renal cell carcinoma treatment (4 papers). Xin Lü is often cited by papers focused on Gene expression and cancer classification (7 papers), Cellular Mechanics and Interactions (6 papers) and Renal cell carcinoma treatment (4 papers). Xin Lü collaborates with scholars based in China, United States and Australia. Xin Lü's co-authors include J. Dirk Iglehart, X. Edward Guo, Zhigang C. Wang, Alexander Miron, Bo Huo, Arcangela De Nicolo, Shridar Ganesan, David M. Livingston, Xiaodong Liao and Myles Brown and has published in prestigious journals such as Nature Medicine, Blood and Bioinformatics.

In The Last Decade

Xin Lü

67 papers receiving 3.2k citations

Hit Papers

X chromosomal abnormalities in basal-like human breast ca... 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Lü China 26 2.0k 850 618 339 307 67 3.3k
Mei Wang China 34 2.4k 1.2× 617 0.7× 718 1.2× 285 0.8× 331 1.1× 146 4.0k
Jian Yuan China 31 2.9k 1.5× 1.2k 1.4× 751 1.2× 344 1.0× 272 0.9× 148 4.1k
Yanping Guo China 29 2.2k 1.1× 1.2k 1.4× 675 1.1× 209 0.6× 382 1.2× 94 4.9k
Yuri Nikolsky United States 34 2.3k 1.2× 622 0.7× 595 1.0× 283 0.8× 155 0.5× 55 3.6k
Michael Khan United Kingdom 24 2.0k 1.0× 796 0.9× 493 0.8× 262 0.8× 168 0.5× 62 3.4k
Seiichi Ishida Japan 24 2.5k 1.3× 1.4k 1.6× 580 0.9× 196 0.6× 150 0.5× 69 3.8k
Jun Du China 33 2.1k 1.1× 730 0.9× 701 1.1× 324 1.0× 382 1.2× 154 3.4k
Shixia Huang United States 30 2.4k 1.2× 1.3k 1.6× 651 1.1× 164 0.5× 372 1.2× 70 3.7k
Javier Hernández‐Losa Spain 33 2.1k 1.1× 982 1.2× 782 1.3× 294 0.9× 385 1.3× 115 3.3k

Countries citing papers authored by Xin Lü

Since Specialization
Citations

This map shows the geographic impact of Xin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Lü more than expected).

Fields of papers citing papers by Xin Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Lü. The network helps show where Xin Lü may publish in the future.

Co-authorship network of co-authors of Xin Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Lü. A scholar is included among the top collaborators of Xin Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Lü. Xin Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Darren C., Fritz G. Buchanan, Dong Cheng, et al.. (2021). Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors. Cancer Research. 81(12). 3402–3414. 32 indexed citations
2.
Wu, Bo, Xin Lü, Haibo Shen, et al.. (2020). Intratumoral heterogeneity and genetic characteristics of prostate cancer. International Journal of Cancer. 146(12). 3369–3378. 33 indexed citations
3.
Lassman, Andrew B., Lisa Roberts-Rapp, И. А. Соколова, et al.. (2019). Comparison of Biomarker Assays for EGFR : Implications for Precision Medicine in Patients with Glioblastoma. Clinical Cancer Research. 25(11). 3259–3265. 25 indexed citations
4.
Guo, Jun, Xiao Yu, Xin Lü, et al.. (2019). Empowering therapeutic antibodies with IFN-α for cancer immunotherapy. PLoS ONE. 14(8). e0219829–e0219829. 20 indexed citations
5.
Liu, Fei, Anwei Liu, Xin Lü, et al.. (2019). Dysbiosis signatures of the microbial profile in tissue from bladder cancer. Cancer Medicine. 8(16). 6904–6914. 96 indexed citations
6.
Wang, Rui, Yupeng He, Ziping Yang, et al.. (2018). Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP. Molecular Cancer Therapeutics. 17(12). 2543–2550. 46 indexed citations
7.
Wang, Kaijian, Chao Wang, Lihe Dai, et al.. (2018). Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer. Clinical Cancer Research. 25(3). 1070–1086. 38 indexed citations
8.
Liu, Zhi‐Yong, Ying-hao SUN, Rui Chen, et al.. (2018). Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases. Asian Journal of Andrology. 20(5). 438–438. 22 indexed citations
9.
Liu, Anwei, Shuxiong Zeng, Xin Lü, et al.. (2018). Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer. International Journal of Biological Macromolecules. 123. 322–334. 41 indexed citations
10.
Bao, Yi, Zhixiang Wang, Bing Liu, et al.. (2018). A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis. Oncogene. 38(6). 881–895. 49 indexed citations
12.
Xie, Hongyu, Wenjie Wang, Fengyu Sun, et al.. (2017). Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer. Scientific Reports. 7(1). 9896–9896. 16 indexed citations
13.
Xiao, Yu, Paul Nimmer, George S. Sheppard, et al.. (2015). MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor. Molecular Cancer Therapeutics. 14(8). 1837–1847. 89 indexed citations
14.
Zhang, Shijie, Weiping Chen, Xin Lü, et al.. (2014). Genomic variants of genes associated with three horticultural traits in apple revealed by genome re-sequencing. Horticulture Research. 1(1). 14045–14045. 28 indexed citations
15.
Lü, Xin, et al.. (2013). Sulfur-containing amino acid methionine as the precursor of volatile organic sulfur compounds in algea-induced black bloom. Journal of Environmental Sciences. 25(1). 33–43. 73 indexed citations
16.
Lü, Xin, Sharlyn J. Mazur, Tongxiang Lin, Ettore Appella, & Yang Xu. (2013). The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene. 33(20). 2655–2664. 133 indexed citations
17.
Huo, Bo, Xin Lü, Kevin D. Costa, Qiaobing Xu, & X. Edward Guo. (2010). An ATP-dependent mechanism mediates intercellular calcium signaling in bone cell network under single cell nanoindentation. Cell Calcium. 47(3). 234–241. 59 indexed citations
18.
Chan, M. Ete, Xin Lü, Bo Huo, et al.. (2009). A Trabecular Bone Explant Model of Osteocyte–Osteoblast Co-Culture for Bone Mechanobiology. Cellular and Molecular Bioengineering. 2(3). 405–415. 33 indexed citations
19.
Lü, Xin, Anthony Gamst, & Ronghui Xu. (2009). RDCurve: A Nonparametric Method to Evaluate the Stability of Ranking Procedures. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 7(4). 719–726. 7 indexed citations
20.
Harris, Lyndsay N., Fanglei You, Stuart J. Schnitt, et al.. (2007). Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer. Clinical Cancer Research. 13(4). 1198–1207. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026